Engineered Drug Delivery of Mesenchymal Stromal Cell Therapy (IMAGE)

AlphaMed Press

Engineered Drug Delivery of Mesenchymal Stromal Cell Therapy

Caption

Engineered Drug Delivery of Mesenchymal Stromal Cell Therapy. (Left) IV infusion of MSCs is limited by low bioavailability. (Right) By incorporating MSCs into an ex vivo blood-contacting device, their bioavailability is enhanced and the release of immunomodulatory factors directly into the bloodstream can be controlled.

Credit

AlphaMed Press

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.